FDA Approved: MIRVASO — Original Application (Galderma Laboratories, L.P.)

View source ↗

Summary

FDA approved Mirvaso (brimonidine tartrate) gel via an original NDA from Galderma Laboratories for the treatment of facial erythema associated with rosacea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• Mirvaso (brimonidine tartrate)

Snippet

ORIG AP for MIRVASO (BRIMONIDINE TARTRATE)